Clinical Pharmacokinetics and Pharmacodynamics of Saxagliptin, a Dipeptidyl Peptidase-4 Inhibitor
Crossref DOI link: https://doi.org/10.1007/s40262-016-0421-4
Published Online: 2016-06-09
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Boulton, David W.
Funding for this research was provided by:
AstraZeneca
License valid from 2016-06-09